By Ahmed Rahma
The United Kingdom government has approved the use of Moderna’s COVID-19 vaccine, making it the third vaccine approved for use in the country.
The US-based company’s vaccine, which was shown to have 94 per cent efficacy against coronavirus in the final trial, was welcomed by Health Secretary, Mr Matt Hancock.
He disclosed that seven million doses had already been ordered by the UK government with a further 10 million expected to follow, but it will likely not become available until March.
The Health Secretary explained that this is because it is being manufactured in the US at first, and will take a few months before manufacturing facilities in Europe will be ready for distribution.
Speaking on the jab, Mr Hancock called it “another weapon in our arsenal to tame this awful disease,” adding that this will boost the counry’s vaccination programme even further once doses become available from March.
However, he urged the people to continue abiding by the rules to lower the number of cases.
“While we immunise those most at risk from COVID, I urge everyone to continue following the rules to keep cases low to protect our loved ones,” the health secretary said.
The American authorities, whose Food and Drug Administration based its decision on results from a late-stage study of 30,000 volunteers, have also approved the Moderna vaccine.
The Moderna vaccine was taken by US vice president-elect Kamala Harris at the end of December on live television to prove its safety.
According to a senior research fellow in global health at the University of Southampton, Dr Micheal Head, when the vaccines arrive in Britain, they will “help to ease any bottlenecks or delays in the administration programme”.
He added that “the jabs’ early usage in the US and other countries have been successful with no significant issues raised in terms of safety”.
The UK was the first country in the world to approve the Pfizer/BioNTech vaccine and has since also begun the rollout of the Oxford/AstraZeneca jab.
On Thursday, the British Prime Minister, Mr Boris Johnson, said 1.26 million jabs had been given in England, 113,000 in Scotland, 49,000 in Wales, and 46,000 in Northern Ireland.
The government has set a target to deliver first doses to 14 million of the most vulnerable by February 15.
The Moderna vaccine is much easier to distribute than the Pfizer jab, which must be stored at about -70C to maintain optimal efficacy.
It has been shown to last for up to 30 days in household fridges, at room temperature for up to 12 hours, and remains stable at -20C – equal to most household or medical freezers – for up to six months.
COVID-19: Nigeria to Start Vaccination of Children
By Ashemiriogwa Emmanuel
In a few months’ time, Nigeria will commence administering vaccines to children under 12 years to protect them against the coronavirus (COVID-19).
This vaccination of children against the virus would be done in partnership with the United Nations Children’s Fund (UNICEF).
The UNICEF Health Specialist and Officer in charge of Enugu Field Office, Mr Olusoji Akinleye, said during a recent media executive meeting in the state that it had taken so long for this to be implemented because of the cluttered processes involved before any drug would be administered to children.
Speaking at the event, which was in collaboration with Broadcasting Corporation of Abia State (BCA), Umuahia, on Child Rights-influenced Reporting on COVID-19, the specialist said that a lot of children had died due to the COVID-19, adding that, “In the next few months, Nigeria will start administering the vaccine on children under 12 years of age.”
He said, “We recognize the partnership in promoting and highlighting the right of every child to life. The very first right that every human being is supposed to have is the right to life; we recognise that the media have always supported the effort of government and partners, including UNICEF, in promoting the right to health.”
Noting the challenges faced by the health sector regarding public hesitancy, unwillingness, and misconceptions against the COVID-19 vaccines, Mr Akinleye encouraged parents to ensure that their children were protected by obeying the safety protocols that have been put in place.
In addition to this, he said, “UNICEF looks forward to more robust collaboration with the media and an expected upward trend in the promotion of health and hygiene practices by the media in Nigeria by daily communication to the public of protocols enforced by the government to prevent the spread of COVID-19.”
Lagos to Host Conference on Biosecurity, One Health
By Sodeinde Temidayo David
The Lagos State Government has announced the plan to hold the seventh Annual African Conference on One Health and Biosecurity as part of efforts to ensure that the Africa continent braces up for the challenges posed by emerging infectious diseases and biosecurity threats.
The conference is in partnership with Global Emerging Pathogens Treatment Consortium (GET) and is scheduled to hold both virtually and physically at the Civic Centre at Lagos from Wednesday, October 27 to Friday, October 29, 2021, with the theme Universal Approach to Addressing Biosecurity Threats – Genomic Intelligence and Vaccines.
Interested participants have been advised to visit the GET website to register and attend the hybrid conference.
According to the state Commissioner for Health, Mr Akin Abayomi, the conference is seventh in the series of conferences organised by GET, in partnership with governments around West Africa and the African continent, to help develop a biosecurity road map and to increase resilience in dealing with pathogens of high consequence.
Mr Abayomi expressed the need to continually focus on the key importance of the African response in combating emerging infectious diseases.
He stated that the need for various treatment strategies and preparedness against future biosecurity threats necessitated the need for the conference.
“Lagos has teamed up once again this year with GET to organise the seventh African Conference on One Health and Biosecurity. We have a very important thematic initiative this year to address the universal approach to biosecurity threats using genomic intelligence and vaccine,” the commissioner noted.
He further explained that genomic intelligence is the ability to sequence a pathogen that is causing an outbreak, adding that COVID-19 is the focus of attention for the conference.
As stated by him, genomic intelligence should be vigorous, with significant measures taken to mitigate the potency of current and future epidemics as well as keeping up with effective vaccine production.
Mr Abayomi further explained that the conference’s thematic areas cover Vaccine Strategy, Genome Research, Emerging Infectious Diseases, Biosecurity and Bio-threat, Biobanking Infrastructure, Climate change and Cultural Anthropological Social and Economic Impact of Emerging Infectious Diseases.
He also advocated various treatment strategies and preparedness against future biosecurity threats as he stated the key importance of the African response in combating Emerging Infectious Diseases,
He stated that Lagos is prepared to welcome participants, policymakers, researchers, scientists and other interested persons to the conference, adding that the concept of One Health is necessary for ensuring biosecurity and all-around health.
In his remarks, the Chief Operating Officer of GET Consortium, Mr Ayodotun Bobadoye, noted that participants at the conference will include policymakers, scientists, researchers, healthcare professionals, experts in infectious disease management, professionals from one health field, development partners, community and opinion leaders amongst others from within and outside the continent.
Mr Bobadoye further noted that resolutions at the conference will help chart a positive course for strategic response against Biosecurity threats in Africa and by extension the world.
NCS Honours LASUTH for Excellence in Cardiovascular Care
By Modupe Gbadeyanka
The Lagos State University Teaching Hospital (LASUTH) has been announced as the winner of the Excellence in Cardiovascular Care Award.
This award was given to LAUSTH on the premises the hospital is renowned for its contribution to the growth and development of cardiovascular medicine and surgery in the country.
The respected health institution grabbed this award at the 50th Annual General Meeting (AGM) and Scientific Conference of the Nigeria Cardiac Society (NCS) held in Lagos recently.
LASUTH is one of the two tertiary hospitals carrying out open-heart surgery in Nigeria. It has continued to make giant strides in improving the lives of the citizens of Lagos State and its environs.
The soon to be quaternary hospital has over the years provided high-quality healthcare to Lagosians using state-of-the-art equipment and cutting-edge technology to solve common and emerging health problems.
LASUTH heart surgeons have performed some of the most advanced procedures in the medical field. The hospital has experienced professionals who specialize in open-heart surgeries that effectively treat heart conditions while minimizing patients’ recovery time and maximizing the best possible outcomes.
This made the NCS during the recently concluded Scientific Conference honour the hospital for her feats and outstanding achievement in tackling cardiovascular diseases through a consistent open-heart surgery with great success.
It was learned that these surgical feats would not have been possible without the expertise of the medical professionals at the LASUTH Cardio-Thoracic Surgery Unit (CTSU) led by Dr Bode Falase, a cardiac surgeon and ably supported by the management of the hospital, under the leadership of the Chief Medical Director, Prof. Adetokunbo Fabamwo.
In a few weeks, LASUTH will be the only government-owned hospital with a cardiac catheterization laboratory (Cathlab). This is a laboratory with special imaging equipment used for the visualization of the arteries and checking blood flow to and from the heart.
LASUTH said one of the advantages of using its facility for cardiovascular issues is that patients would be exceptionally cared for at a reduced cost while also reducing medical tourism.
Like Our Facebook Page
Latest News on Business Post
- NGX Group Gains 10% to Lift Stock Market by 0.26% October 21, 2021
- Naira Appreciates to N414.07/$1 as Bitcoin Hits $66k October 21, 2021
- Oil Prices Continue Ascent as US Crude Inventories Drop October 21, 2021
- Unlisted Securities Extend Rally by 0.38% at Midweek October 21, 2021
- Turkey Sees Bilateral Trade Volume with Nigeria Expanding to $5bn October 20, 2021
- 2021 NGX Market Data Workshop Gathers Momentum October 20, 2021
- What You Need to Know About Education Trust October 20, 2021
- ADVAN Kicks Against APCON’s Code of Conduct October 20, 2021
- We Cater for Over 17.5 Million Nigerian Orphans—SOS Children’s Villages October 20, 2021
- 200 Retirees in Jigawa to Share N331.7m October 20, 2021
Feature/OPED2 years ago
Davos was Different this year
Economy5 years ago
Kwara Disburses N1.7b For Projects
Technology10 months ago
How To Link Your MTN, Airtel, Glo, 9mobile Lines to NIN
Travel/Tourism5 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
Economy5 years ago
How To Identify Fake Naira Notes
Banking3 years ago
Sort Codes of GTBank Branches in Nigeria
Economy4 years ago
FAAC: FG, States, LGs Share N655.18b in January
Economy4 years ago
NSE Market Capitalisation Sheds N76b as Sell‐offs Persist